Viewing Study NCT07112456

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:18 PM
Ignite Modification Date: 2026-01-23 @ 8:33 PM
Study NCT ID: NCT07112456
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-08-08
First Post: 2025-07-22
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Nebulized Ketamine Plus Standard Care vs. Standard Care Alone in Moderate to Severe Asthma Exacerbations
Sponsor: Oman Medical Speciality Board
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Asthma Acute View
None Asthma Attack View
None Asthma Exacerbations View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Asthma View
None Asthma, Severe View
None Asthma Exacerbation View
None Emergency Treatment View
None Ketamine View
None Ketamine, Nebulized View
None Bronchodilator Agents View
None Randomized Controlled Trial View
None Peak Expiratory Flow Rate View
None Safety and Efficacy View